CATALAYER NEWS
Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs - BioPharma Dive
Source: BioPharma Dive · 2026-03-06
Full article text is available in the Catalayer news terminal.
MORE FROM BIOPHARMA DIVE
Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks - BioPharma Dive
2026-05-29
RELATED ON CATALAYER
Mentioned Tickers
$PFE · PfizerRelated Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets